UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 2, 2007
AETHLON MEDICAL, INC.
(Exact name of Registrant as specified in charter)
Nevada 000-21846 13-3632859
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification Number)
3030 Bunker Hill Street, Suite 4000
San Diego, California 92109
(Address of principal executive offices)
Registrant's telephone number, including area code: (858) 459-7800
NOT APPLICABLE
(Former name or former address, if changed since last report)
FORWARD LOOKING STATEMENTS
This Form 8-K and other reports filed by Registrant from time to time
with the Securities and Exchange Commission (collectively the "Filings") contain
or may contain forward looking statements and information that are based upon
beliefs of, and information currently available to, Registrant's management as
well as estimates and assumptions made by Registrant's management. When used in
the Filings the words "anticipate, "believe", "estimate", "expect", "future",
"intend", "plan" or the negative of these terms and similar expressions as they
relate to Registrant or Registrant's management identify forward looking
statements. Such statements reflect the current view of Registrant with respect
to future events and are subject to risks, uncertainties, assumptions and other
factors relating to Registrant's industry, Registrant's operations and results
of operations and any businesses that may be acquired by Registrant. Should one
or more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those
anticipated, believed, estimated, expected, intended or planned.
Although Registrant believes that the expectations reflected in the
forward looking statements are reasonable, Registrant cannot guarantee future
results, levels of activity, performance or achievements. Except as required by
applicable law, including the securities laws of the United States, Registrant
does not intend to update any of the forward-looking statements to conform these
statements to actual results.
ITEM 5.03 Amendments to Articles of Incorporation or Bylaws
On March 2, 2007, Aethlon Medical, Inc. (the "Company") held an annual
meeting of stockholders at the Company's executive offices for the following
purposes: (1) to elect Messers. James Joyce, Frank Barry, Dr. Richard Tullis and
Ed Broenniman (collectively, the "Nominated Board") to serve as directors of the
Company (2) to ratify the appointment of Squar, Milner, Peterson, Miranda &
Williamson, L.L.P. ("Squar Milner"), as the Company's independent auditors for
the fiscal year ending March 31, 2007 and (3) to approve an amendment to the
Company's Articles of Incorporation to increase the number of authorized shares
of the Company's common stock from 50,000,000 to 100,000,000. Stockholders
holding an aggregate of 21,763,109 shares of common stock of the Company voted
in favor of electing the Nominated Board; stockholders holding an aggregate of
21,811,789 shares of common stock of the Company voted in favor to ratify the
appointment of Squar Milner as the Company's independent auditors and
stockholders holding an aggregate of 8,628,045 shares of common stock of the
Company voted in favor of approving the amendment to the Company's Articles of
Incorporation to increase the number of authorized shares of common stock from
50,000,000 to 100,000,000. There were 12,363,691 shares represented by broker
non-votes in connection with the proposal to increase the Company's number of
authorized shares of the Company's common stock. The number of shares voted in
favor of the three proposals was sufficient for the approval of both proposals.
A Form of Certificate of Amendment to the Articles of Incorporation is filed as
an exhibit to this current report on Form 8-K.
2
ITEM 9.01 Financial Statements and Exhibits
(a) Financial Statements of Businesses Acquired. Not applicable.
(b) Pro Forma Financial Information Not applicable.
(c) Exhibits
Exh. No. Description
-------- -----------
3.1 Form of Certificate of Amendment to Articles of
Incorporation
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: March 7, 2007 AETHLON MEDICAL, INC.
By: /s/ James A. Joyce
----------------------------
James A. Joyce
Chief Executive Officer
3
EXHIBITS FILED WITH THIS REPORT
Exh. No. Description
-------- -----------
3.1 Form of Certificate of Amendment to Articles of Incorporation
4